Human pluripotent stem cells such as donor-derived human induced pluripotent stem cells (hiPSCs) are now widely used for disease modelling, drug screening and certainly cell replacement therapy.
Asst Prof. Adrian Teo will discuss basic knowledge on stem cells, patient-derived hiPSCs and the broad cell types that they can be differentiated into for understanding human disease mechanisms. He will also give an overview of current efforts in hiPSC-based cell therapy clinical trials.